| . | EH (N = 12) . | ARAS (N = 12) . | P-value . |
|---|---|---|---|
| Gender, male (%) | 50 | 50 | |
| Age (years) | 64 ± 15 | 72 ± 6 | 0.05 |
| SBP (mmHg) | 132 ± 18 | 155 ± 18 | 0.002 |
| DBP (mmHg) | 71 ± 11 | 72 ± 12 | 0.36 |
| BMI (kg/m2) | 26.2 ± 4.1 | 31.6 ± 9.4 | 0.04 |
| ACEI or ARBs, yes/no (n/n) | 11/1 | 12/12 | |
| Statins, yes (%) | 6 (50%) | 12 (100%) | |
| Creatinine (mg/dL) | 0.97 ± 0.26 | 1.68 ± 0.49 | <0.0001 |
| Iothalamate clearance GFR (mL/min) | 77 ± 25 | 48 ± 21 | 0.003 |
| Hematocrit (%) | 38.5 ± 4.2 | 37.2 ± 3.1 | 0.18 |
| Total cholesterol (mg/dL) | 189 ± 26 | 162 ± 50 | 0.07 |
| TG (mg/dL) | 131 ± 62 | 146 ± 69 | 0.32 |
| HDL (mg/dL) | 57 ± 11 | 45 ± 11 | 0.02 |
| LDL (mg/dL) | 106 ± 19 | 72 ± 23 | 0.002 |
| IGFBP7 (pg/mL) | 14.59 | 13.24 | 0.004 |
| TIMP-2 (pg/mL) | 99.39 | 86.57 | 0.08 |
| . | EH (N = 12) . | ARAS (N = 12) . | P-value . |
|---|---|---|---|
| Gender, male (%) | 50 | 50 | |
| Age (years) | 64 ± 15 | 72 ± 6 | 0.05 |
| SBP (mmHg) | 132 ± 18 | 155 ± 18 | 0.002 |
| DBP (mmHg) | 71 ± 11 | 72 ± 12 | 0.36 |
| BMI (kg/m2) | 26.2 ± 4.1 | 31.6 ± 9.4 | 0.04 |
| ACEI or ARBs, yes/no (n/n) | 11/1 | 12/12 | |
| Statins, yes (%) | 6 (50%) | 12 (100%) | |
| Creatinine (mg/dL) | 0.97 ± 0.26 | 1.68 ± 0.49 | <0.0001 |
| Iothalamate clearance GFR (mL/min) | 77 ± 25 | 48 ± 21 | 0.003 |
| Hematocrit (%) | 38.5 ± 4.2 | 37.2 ± 3.1 | 0.18 |
| Total cholesterol (mg/dL) | 189 ± 26 | 162 ± 50 | 0.07 |
| TG (mg/dL) | 131 ± 62 | 146 ± 69 | 0.32 |
| HDL (mg/dL) | 57 ± 11 | 45 ± 11 | 0.02 |
| LDL (mg/dL) | 106 ± 19 | 72 ± 23 | 0.002 |
| IGFBP7 (pg/mL) | 14.59 | 13.24 | 0.004 |
| TIMP-2 (pg/mL) | 99.39 | 86.57 | 0.08 |
GFR, glomerular filtration rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; N, number of patients; ACEI, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptors blockers.
| . | EH (N = 12) . | ARAS (N = 12) . | P-value . |
|---|---|---|---|
| Gender, male (%) | 50 | 50 | |
| Age (years) | 64 ± 15 | 72 ± 6 | 0.05 |
| SBP (mmHg) | 132 ± 18 | 155 ± 18 | 0.002 |
| DBP (mmHg) | 71 ± 11 | 72 ± 12 | 0.36 |
| BMI (kg/m2) | 26.2 ± 4.1 | 31.6 ± 9.4 | 0.04 |
| ACEI or ARBs, yes/no (n/n) | 11/1 | 12/12 | |
| Statins, yes (%) | 6 (50%) | 12 (100%) | |
| Creatinine (mg/dL) | 0.97 ± 0.26 | 1.68 ± 0.49 | <0.0001 |
| Iothalamate clearance GFR (mL/min) | 77 ± 25 | 48 ± 21 | 0.003 |
| Hematocrit (%) | 38.5 ± 4.2 | 37.2 ± 3.1 | 0.18 |
| Total cholesterol (mg/dL) | 189 ± 26 | 162 ± 50 | 0.07 |
| TG (mg/dL) | 131 ± 62 | 146 ± 69 | 0.32 |
| HDL (mg/dL) | 57 ± 11 | 45 ± 11 | 0.02 |
| LDL (mg/dL) | 106 ± 19 | 72 ± 23 | 0.002 |
| IGFBP7 (pg/mL) | 14.59 | 13.24 | 0.004 |
| TIMP-2 (pg/mL) | 99.39 | 86.57 | 0.08 |
| . | EH (N = 12) . | ARAS (N = 12) . | P-value . |
|---|---|---|---|
| Gender, male (%) | 50 | 50 | |
| Age (years) | 64 ± 15 | 72 ± 6 | 0.05 |
| SBP (mmHg) | 132 ± 18 | 155 ± 18 | 0.002 |
| DBP (mmHg) | 71 ± 11 | 72 ± 12 | 0.36 |
| BMI (kg/m2) | 26.2 ± 4.1 | 31.6 ± 9.4 | 0.04 |
| ACEI or ARBs, yes/no (n/n) | 11/1 | 12/12 | |
| Statins, yes (%) | 6 (50%) | 12 (100%) | |
| Creatinine (mg/dL) | 0.97 ± 0.26 | 1.68 ± 0.49 | <0.0001 |
| Iothalamate clearance GFR (mL/min) | 77 ± 25 | 48 ± 21 | 0.003 |
| Hematocrit (%) | 38.5 ± 4.2 | 37.2 ± 3.1 | 0.18 |
| Total cholesterol (mg/dL) | 189 ± 26 | 162 ± 50 | 0.07 |
| TG (mg/dL) | 131 ± 62 | 146 ± 69 | 0.32 |
| HDL (mg/dL) | 57 ± 11 | 45 ± 11 | 0.02 |
| LDL (mg/dL) | 106 ± 19 | 72 ± 23 | 0.002 |
| IGFBP7 (pg/mL) | 14.59 | 13.24 | 0.004 |
| TIMP-2 (pg/mL) | 99.39 | 86.57 | 0.08 |
GFR, glomerular filtration rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; N, number of patients; ACEI, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptors blockers.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
